"Herzlich willkommen bei DONAUISAR Klinikum Deggendorf-Dingolfing-Landau! Das DONAUISAR Klinikum Deggendorf leistet als Haus der II. Versorgungsstufe einen sehr wichtigen Beitrag nicht nur für die medizinische Versorgung der Landkreisbevölkerung, sondern darüber hinaus der ganzen Region. Der Standort Deggendorf verfügt über 17 Stationen (inkl. Intensivstationen) mit derzeit 470 Betten, 9 Funktionsabteilungen, einer Palliativstation mit 10 Betten, 10 Dialysebetten und einer Akutgeriatrischen Hauptabteilung. Bei Fragen können Sie uns gerne kontaktieren. Wir freuen uns Ihnen helfen zu können! Ihre DONAUISAR Klinikum Deggendorf-Dingolfing-Landau"

During the past decade, Donauisar Klinikum Deggendorf conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Donauisar Klinikum Deggendorf" #1 sponsor was "ETOP IBCSG Partners Foundation" with 2 trials, followed by "Spinal Stabilization Technologies" with 2 trials sponsored, "AIO-Studien-gGmbH" with 1 trials sponsored, "ClarData" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Donauisar Klinikum Deggendorf" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Donauisar Klinikum Deggendorf" are "Breast Cancer" (5 trials), "Chronic Low-back Pain" (2 trials), "Degenerative Disc Disease" (2 trials), "Breast Neoplasms" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Donauisar Klinikum Deggendorf" in a lesser frequency.

Most popular intervention types in "Donauisar Klinikum Deggendorf" are "Drug" (12 trials), "Biological" (2 trials), "Device" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "docetaxel" (2 trials), "epirubicin hydrochloride" (2 trials), "Atezolizumab" (1 trials) and "Barricaid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Donauisar Klinikum Deggendorf" are 11 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Donauisar Klinikum Deggendorf". 1 are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Donauisar Klinikum Deggendorf, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Donauisar Klinikum Deggendorf, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Donauisar Klinikum Deggendorf has several departments that took part in Clinical trials: "DONAU ISAR Klinikum Deggendorf; Frauenklinik" - 2 trials